lobbying_filings_raw: 29f771f8-cc95-4f89-a75e-ee270ff31e05
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29f771f8-cc95-4f89-a75e-ee270ff31e05 | Q2 | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 131178 | MASSACHUSETTS MEDICAL SOCIETY | 2018 | second_quarter | 2018-07-18T15:03:50.067000-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/29f771f8-cc95-4f89-a75e-ee270ff31e05/", "filing_uuid": "29f771f8-cc95-4f89-a75e-ee270ff31e05", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2018, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/29f771f8-cc95-4f89-a75e-ee270ff31e05/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "70000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Lois Dehls Cornell, Executive Vice President", "dt_posted": "2018-07-18T15:03:50.067000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "860 WINTER STREET", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WALTHAM", "registrant_state": "MA", "registrant_zip": "02451", "registrant": {"id": 23975, "url": "https://lda.senate.gov/api/v1/registrants/23975/", "house_registrant_id": 31967, "name": "MASSACHUSETTS MEDICAL SOCIETY", "description": null, "address_1": "860 WINTER STREET", "address_2": null, "address_3": null, "address_4": null, "city": "WALTHAM", "state": "MA", "state_display": "Massachusetts", "zip": "02451", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "LOIS DEHLS CORNELL", "contact_telephone": "+1 781-893-4610", "dt_updated": "2026-01-26T15:50:30.533101-05:00"}, "client": {"id": 131178, "url": "https://lda.senate.gov/api/v1/clients/131178/", "client_id": 12, "name": "MASSACHUSETTS MEDICAL SOCIETY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "MA", "state_display": "Massachusetts", "country": "US", "country_display": "United States of America", "ppb_state": "MA", "ppb_state_display": "Massachusetts", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "1996-02-14"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Increased funding and focus on the social determinants of health, including food - No specific bill\n\n\nS. 771 - Improving Access to Affordable Prescription Drugs - Legislation that seeks to address prescription drug costs by increasing transparency and accountability, boosting access and affordability of key drugs, spurring innovation, and increasing choice and competition by allowing Medicare to negotiate the price of drugs, among other provisions.\n\nEfforts to address the cost of prescription drugs, including proposals to include the manufacturers suggested retail price in direct to consumer advertising of prescription drugs - no specific bill\n\nOpioids\n\nHR 6 - SUPPORT for Patients and Communities Act\n\nHR 1375 - Prescriber Support Act - Grants to states for programs to help prescribers (1) treat and manage patient pain; and (2) prevent, identify, and respond to patient substance misuse and substance abuse disorder\n\nHR 3528 - Every Prescription Conveyed Securely Act - mandated eprescribing of controlled substances\n\nS. 1554 - Safer Prescribing of Controlled Substances Act - Federal Mandates for Opioid Prescriber Education \n\nH.R.5102 - Substance Use Disorder Workforce Loan Repayment Act of 2018 - Federal Student Loan forgiveness for substance abuse prevention and treatment professionals\n\nHR 4097 - Medicare Beneficiary Opioid Addiction Treatment Act - access for Medicare beneficiaries to MAT\n\nSafe Injection Facilities - no specific bill\n\nHR 4778 - S. 2301 Behavioral Health Coverage Transparency Act- requirements for transparency in behavioral health coverage\n\nExpanded Access to MAT, Naloxone, treatment, prevention and recovery programs for substance abuse disorder - no specific bill\n\nHR 5545/S. 5102 Comprehensive Addiction Resources Emergency (Care) Act of 2018\n\nHR 5311/S. 2456 CARA 2.0 Act of 2018\n\nPhysician Burnout & Wellness - no specific bill\n\n\n\nTelemedicine\n\nS. 870 - Creating High Quality Results and Outcomes Necessary to Improve Chronic Care\n\nHR 2556 - Connect for Health Act of 2017\n \nS. 2574/HR 2276 - Audiology Patient Choice - oppose changing Medicare reimbursement to include audiologists in definition of physician\n\nRegulatory Issues\n\n\nElectronic medical records - efforts to streamline and improve interoperability \n\nDEA issues \nUpdated regulations to implement Partial Fill law\n Updated regulations for Eprescribing of Controlled Substances\n\nDepartment of Health and Human Services: Protecting Statutory Conscience Rights in Health care, Delegations of Authority. 45 CFR, Part 88, HHS-OCR-2018-0002; RIN 0945-ZA03\n\n\nOpposition to Medicaid Point of Care Testing Cuts as part of the Clinical Laboratory Fee Schedule\n\nThe Office of Population Affairs (OPA), in the Office of the Assistant Secretary for Health, proposes to revise its Title X regulations (Title X of the Public Health Service Act) to ensure compliance with, and enhance implementation of, the statutory requirement that none of the funds appropriated for Title X may be used in programs where abortion is a method of family planning and related statutory requirements. (Docket No.: HHS-OS-2018-0008;42 CFR Part 59; RIN 0937-ZA00 Compliance with Statutory Program Integrity Requirements)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Increased funding and focus on the social determinants of health, including food - No specific bill\n\nOpposition to proposed cuts to the Supplemental Nutrition Assistance Program - No specific bill\n\nHR 496 - S 128 The Bridge Act - DACA protections\n\nSeparation of Immigrant Children From Their Families - No specific bill\n\nPrescription Drug Prices\n\nS. 771 - Improving Access to Affordable Prescription Drugs - Legislation that seeks to address prescription drug costs by increasing transparency and accountability, boosting access and affordability of key drugs, spurring innovation, and increasing choice and competition by allowing Medicare to negotiate the price of drugs, among other provisions.\n\nEfforts to address the cost of prescription drugs, including proposals to include the manufacturers suggested retail price in direct to consumer advertising of prescription drugs - no specific bill\n\nOpioids\n\nHR 6 - SUPPORT for Patients and Communities Act\n\nHR 1375 - Prescriber Support Act - Grants to states for programs to help prescribers (1) treat and manage patient pain; and (2) prevent, identify, and respond to patient substance misuse and substance abuse disorder\n\nHR 3528 - Every Prescription Conveyed Securely Act - mandated eprescribing of controlled substances\n\nS. 1554 - Safer Prescribing of Controlled Substances Act - Federal Mandates for Opioid Prescriber Education \n\nH.R.5102 - Substance Use Disorder Workforce Loan Repayment Act of 2018 - Federal Student Loan forgiveness for substance abuse prevention and treatment professionals\n\nHR 4097 - Medicare Beneficiary Opioid Addiction Treatment Act - access for Medicare beneficiaries to MAT\n\nSafe Injection Facilities - no specific bill\n\nHR 4778 - S. 2301 Behavioral Health Coverage Transparency Act- requirements for transparency in behavioral health coverage\n\nExpanded Access to MAT, Naloxone, treatment, prevention and recovery programs for substance abuse disorder - no specific bill\n\nHR 5545/S. 5102 Comprehensive Addiction Resources Emergency (Care) Act of 2018\n\nHR 5311/S. 2456 CARA 2.0 Act of 2018\n\nPhysician Burnout & Wellness - no specific bill\n\nGun Violence\n\nHR 1832, S.834 - A bill to authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention.\n\nS. 2546 - Making America Safe and Secure Act of 2018 - MASS Act\n\nS. 1701 - Fair Access to Science and Technology Act - changes to copyright protections for publications\n\nChanges to Sunshine Act Regarding Patient education materials - no specific bill\n\nTelemedicine\n\nS. 870 - Creating High Quality Results and Outcomes Necessary to Improve Chronic Care\n\nHR 2556 - Connect for Health Act of 2017\n \nS. 2574/HR 2276 - Audiology Patient Choice - oppose changing Medicare reimbursement to include audiologists in definition of physician\n\nRegulatory Issues\n\nElectronic medical records - efforts to streamline and improve interoperability \n\nDEA issues \nUpdated regulations to implement Partial Fill law\n Updated regulations for Eprescribing of Controlled Substances\n \nDepartment of Labor : Definition of Employer Under Section 3(5) of ERISA - Association Health Plans (RIN 1210-AB85): Proposal creating association health plans\n\nDepartment of Health and Human Services: Protecting Statutory Conscience Rights in Health care, Delegations of Authority. 45 CFR, Part 88, HHS-OCR-2018-0002; RIN 0945-ZA03\n\nProposed Rule on Short-Term, Limited-Duration Insurance (CMS-9923-P; RIN 0938-AT48)\n\nOpposition to Medicaid Point of Care Testing Cuts as part of the Clinical Laboratory Fee Schedule\n\nThe Office of Population Affairs (OPA), in the Office of the Assistant Secretary for Health, proposes to revise its Title X regulations (Title X of the Public Health Service Act) to ensure compliance with, and enhance implementation of, the statutory requirement that none of the funds appropriated for Title X may be used in programs where abortion is a method of family planning and related statutory requirements. (Docket No.: HHS-OS-2018-0008;42 CFR Part 59; RIN 0937-ZA00 Compliance with Statutory Program Integrity Requirements)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ALC", "general_issue_code_display": "Alcohol and Drug Abuse", "description": "Opioids\n\nHR 6 - SUPPORT for Patients and Communities Act\n\nHR 1375 - Prescriber Support Act - Grants to states for programs to help prescribers (1) treat and manage patient pain; and (2) prevent, identify, and respond to patient substance misuse and substance abuse disorder\n\nHR 3528 - Every Prescription Conveyed Securely Act - mandated eprescribing of controlled substances\n\nS. 1554 - Safer Prescribing of Controlled Substances Act - Federal Mandates for Opioid Prescriber Education \n\nH.R.5102 - Substance Use Disorder Workforce Loan Repayment Act of 2018 - Federal Student Loan forgiveness for substance abuse prevention and treatment professionals\n\nHR 4097 - Medicare Beneficiary Opioid Addiction Treatment Act - access for Medicare beneficiaries to MAT\n\nSafe Injection Facilities - no specific bill\n\nHR 4778 - S. 2301 Behavioral Health Coverage Transparency Act- requirements for transparency in behavioral health coverage\n\nExpanded Access to MAT, Naloxone, treatment, prevention and recovery programs for substance abuse disorder - no specific bill\n\nHR 5545/S. 5102 Comprehensive Addiction Resources Emergency (Care) Act of 2018\n\nHR 5311/S. 2456 CARA 2.0 Act of 2018\n\nPhysician Burnout & Wellness - no specific bill", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FIR", "general_issue_code_display": "Firearms/Guns/Ammunition", "description": "Gun Violence\n\nHR 1832, S.834 - A bill to authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention.\n\nS. 2546 - Making America Safe and Secure Act of 2018 - MASS Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "IMM", "general_issue_code_display": "Immigration", "description": "HR 496, S. 128 - Bridge Act - Codifies DACA protections for three years. \n \nSeparation of Immigrant Children From Their Families - No specific bill", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "S. 1701 - Fair Access to Science and Technology Act - changes to copyright protections for publications\n\nChanges to Sunshine Act Regarding Patient education materials - no specific bill", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "S. 771 - Improving Access to Affordable Prescription Drugs - Legislation that seeks to address prescription drug costs by increasing transparency and accountability, boosting access and affordability of key drugs, spurring innovation, and increasing choice and competition by allowing Medicare to negotiate the price of drugs, among other provisions.\n\nEfforts to require the manufacturers suggested retail price of prescription drugs in direct to consumer advertising of prescription drugs - no specific bill", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 4482, "prefix": null, "prefix_display": null, "first_name": "ALEXANDRA", "nickname": null, "middle_name": "B", "last_name": "CALCAGNO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | MA | US | 31967 | MA | MA | US | US | 0 | 0 | 70000.0 |